Arvinas, Inc. Common Stock

ARVN US04335A1051

💰
Capitalization
Small-cap

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

🔗
Website
https://www.arvinas.com
Annual Performance 1
2021 2022 2023 2024 2025
-2% -58% 23% -54% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
17
🙍
Insiders
9
Person Price Shares Total Published Completed
Morrison Briggs
 7.57
USD 		30,000
Bought 		227,010
USD 		22/09/2025 22/09/2025
Saik Andrew
CFO 		7.61
USD 		5,700
Sold 		43,377
USD 		24/06/2025 24/06/2025
Cacace Angela M
CSO 		7.49
USD 		2,583
Sold 		19,347
USD 		17/06/2025 17/06/2025
Berkowitz Noah
CMO 		8.59
USD 		8,658
Sold 		74,372
USD 		18/03/2025 18/03/2025
Taylor Ian
PR 		16.55
USD 		1,664
Sold 		27,539
USD 		24/02/2025 24/02/2025
Cacace Angela M
CSO 		16.55
USD 		1,146
Sold 		18,966
USD 		24/02/2025 24/02/2025
Houston John G
CEO 		16.75
USD 		26,184
Sold 		438,582
USD 		24/02/2025 24/02/2025
Taylor Ian
PR 		16.75
USD 		7,356
Sold 		123,213
USD 		24/02/2025 24/02/2025
Houston John G
CEO 		16.55
USD 		5,154
Sold 		85,299
USD 		24/02/2025 24/02/2025
Cacace Angela M
CSO 		16.75
USD 		3,061
Sold 		51,272
USD 		24/02/2025 24/02/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Arvinas, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-27% -35% -58% -38% -46% 0% 18%
Last 52W Low 52W High All-Time Low All-Time High β
9.75 6.07 28.04 6.07 107.87
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Houston John G 3 768,352.50 256,117.50 23/02/2024 24/02/2025
Taylor Ian 3 230,784.25 76,928.08 23/02/2024 24/02/2025
Morrison Briggs 1 227,010.00 227,010.00 22/09/2025 22/09/2025
Cacace Angela M 3 89,584.72 29,861.57 24/02/2025 17/06/2025
Cassidy Sean A 1 80,079.10 80,079.10 23/02/2024 23/02/2024
Peck Ronald 1 79,937.95 79,937.95 23/02/2024 23/02/2024
Berkowitz Noah 1 74,372.22 74,372.22 18/03/2025 18/03/2025
Saik Andrew 1 43,377.00 43,377.00 24/06/2025 24/06/2025
Loomis David K 3 30,635.34 10,211.78 08/11/2023 24/02/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.